Center-Authored Papers

Filters: Author is Hillier, Sharon L  [Clear All Filters]
2010
Marrazzo JM, Martin DH, Watts HD, Schulte J, Sobel JD, Hillier SL, Deal C, Fredricks DN.  2010.  Bacterial vaginosis: identifying research gaps proceedings of a workshop sponsored by DHHS/NIH/NIAID.. Sexually transmitted diseases. 37(12):732-44. Abstract
2011
Dezzutti CS, Hendrix CW, Marrazzo JM, Pan Z, Wang L, Louissaint N, Kalyoussef S, Torres MN, Hladik F, Parikh U et al..  2011.  Performance of swabs, lavage, and diluents to quantify biomarkers of female genital tract soluble mucosal mediators.. PloS one. 6(8):e23136. Abstract
Scott ME, Wilson SS, Cosentino LA, Richardson BA, Moscicki A-B, Hillier SL, Herold BC.  2011.  Interlaboratory reproducibility of female genital tract cytokine measurements by Luminex: implications for microbicide safety studies.. Cytokine. 56(2):430-4. Abstract
2012
Dezzutti CS, Richardson BA, Marrazzo JM, Tugetman J, Ramjee G, Taha T, Chirenje ZM, Abdool Karim SS, Hillier SL, Herold BC.  2012.  Mucosal Escherichia coli Bactericidal Activity and Immune Mediators Are Associated With HIV-1 Seroconversion in Women Participating in the HPTN 035 Trial.. The Journal of infectious diseases. 206(12):1931-5. Abstract
2014
Herold BC, Dezzutti CS, Richardson BA, Marrazzo J, Mesquita PMM, Carpenter C, Huber A, Louissaint N, Marzinke MA, Hillier SL et al..  2014.  Antiviral Activity of Genital Tract Secretions following Oral or Topical Tenofovir Pre-exposure Prophylaxis for HIV-1.. Journal of acquired immune deficiency syndromes (1999). Abstract
Guffey BM, Richardson B, Husnik M, Makanani B, Chilongozi D, Yu E, Ramjee G, Mgodi N, Gomez K, Hillier SL et al..  2014.  HPTN 035 phase II/IIb randomised safety and effectiveness study of the vaginal microbicides BufferGel and 0.5% PRO 2000 for the prevention of sexually transmitted infections in women.. Sexually transmitted infections. Abstract
2015
Austin MN, Rabe LK, Srinivasan S, Fredricks DN, Wiesenfeld HC, Hillier SL.  2015.  Mageeibacillus indolicus gen. nov., sp. nov.: A novel bacterium isolated from the female genital tract.. Anaerobe. 32:37-42. Abstract
Marrazzo JM, Ramjee G, Richardson BA, Gomez K, Mgodi N, Nair G, Palanee T, Nakabiito C, van der Straten A, Noguchi L et al..  2015.  Tenofovir-based preexposure prophylaxis for HIV infection among African women.. The New England journal of medicine. 372(6):509-18. Abstract
Noguchi LM, Richardson BA, Baeten JM, Hillier SL, Balkus JE, Chirenje MZ, Bunge K, Ramjee G, Nair G, Palanee-Phillips T et al..  2015.  Risk of HIV-1 acquisition among women who use different types of injectable progestin contraception in South Africa: a prospective cohort study.. The lancet HIV. 2(7):e279-e287. Abstract
Murphy K, Richardson BA, Dezzutti CS, Marrazzo J, Hillier SL, Hendrix CW, Herold BC.  2015.  Levels of Genital Tract Defensins and Cytokines Differ between HIV-Uninfected US and African Women.. American journal of reproductive immunology (New York, N.Y. : 1989). Abstract
Madan RP, Dezzutti CS, Rabe L, Hillier SL, Marrazzo J, McGowan I, Richardson BA, Herold BC.  2015.  Soluble Immune Mediators and Vaginal Bacteria Impact Innate Genital Mucosal Antimicrobial Activity in Young Women.. American journal of reproductive immunology (New York, N.Y. : 1989). Abstract
2016
Noguchi LM, Montgomery ET, Biggio JR, Hendrix CW, Bogen DL, Hillier SL, Dai JY, Piper JM, Marzinke MA, Dezzutti CS et al..  2016.  Detectable Tenofovir Levels in Breast-Feeding Infants of Mothers Exposed to Topical Tenofovir.. Antimicrobial agents and chemotherapy. 60(9):5616-5619. Abstract
Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L et al..  2016.  Oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial.. Contraception. 93(1):25-31. Abstract
Balkus JE, Brown ER, Hillier SL, Coletti A, Ramjee G, Mgodi N, Makanani B, Reid C, Martinson F, Soto-Torres L et al..  2016.  Corrigendum to "oral and injectable contraceptive use and HIV acquisition risk among women in four African countries: a secondary analysis of data from a microbicide trial" [contraception 2016; 93 (1): 25-31].. Contraception. 94(1):95.
2017
Baeten JM, Brown ER, Hillier SL.  2017.  Dapivirine Vaginal Ring for HIV-1 Prevention.. The New England journal of medicine. 376(10):995-6.
Husnik MJ, Brown ER, Marzinke M, Livant E, Palanee-Phillips T, Hendrix C, Kiweewa FM, Nair G, Soto-Torres LE, Schwartz K et al..  2017.  Implementation of a Novel Adherence Monitoring Strategy in a Phase III, Blinded, Placebo-Controlled, HIV-1 Prevention Clinical Trial.. Journal of acquired immune deficiency syndromes (1999). Abstract